Size: 5mg
Contents: CJC-1295 without DAC
Form: Lyophilized powder
Purity: >99%
CJC-1295 without DAC 5mg is a high-purity, research-grade peptide classified as a short-acting Growth Hormone Releasing Hormone (GHRH) analog, commonly referred to as Mod GRF 1-29. Designed for in-vitro and preclinical research, it is specifically developed to support investigations into pulsatile growth hormone (GH) secretion, endocrine signaling, and somatotropic pathway dynamics.
Unlike DAC-conjugated variants, CJC-1295 without DAC features a shorter half-life, making it an ideal compound for researchers studying time-dependent GH release patterns and controlled stimulation protocols. Its enhanced stability over native GHRH(1-29) ensures reliable and reproducible outcomes in laboratory environments.
CJC-1295 without DAC 5mg is widely recognized in research for its ability to mimic natural GHRH activity while offering improved resistance to enzymatic degradation. Its short-acting profile allows for precise control over growth hormone release, making it particularly valuable in studies focused on pulsatile secretion and hormone timing.
Researchers exploring endocrine function, GH axis regulation, and peptide synergy frequently utilize this compound in combination studies with Growth Hormone Secretagogues (GHS). Its predictable pharmacokinetic profile makes it a preferred tool for controlled experimental designs.
Peptide Type: GHRH analog (Mod GRF 1-29)
Compound: CJC-1295 without DAC
Target Receptor: GHRH receptors
Primary Function: Pulsatile growth hormone release research
CJC-1295 without DAC 5mg functions by binding to GHRH receptors located in the pituitary gland, activating signaling pathways responsible for growth hormone synthesis and release.
Due to its short duration of activity, it closely mimics the body’s natural GH pulse rhythm. This allows researchers to study transient hormone spikes and controlled secretion patterns. Its improved structural stability helps maintain activity long enough for precise experimental observation without prolonged receptor stimulation.
CJC-1295 without DAC 5mg is widely utilized in laboratory studies focused on:
Its short-acting nature makes it especially valuable in research requiring controlled timing and repeatable GH release cycles.
In controlled research environments, CJC-1295 without DAC has demonstrated reliable activation of growth hormone pathways while maintaining a short activity window. This makes it particularly useful for studying physiological hormone rhythms rather than continuous stimulation.
Researchers continue to explore its applications in combination protocols and endocrine timing studies, where precise control over hormone release is essential. Its role in modeling natural GH pulses reinforces its importance in advanced peptide research.
Product Name: CJC-1295 without DAC
Quantity: 5mg per vial
Form: Lyophilized powder
Purity: ≥99%
Store CJC-1295 without DAC 5mg in a cool, dry place away from direct light. Refrigeration is recommended to maintain stability, especially after reconstitution in research settings.
CJC-1295 without DAC 5mg is intended strictly for research and laboratory use only. It is not approved for human consumption, veterinary use, or therapeutic applications. All handling must be performed by qualified professionals in compliance with applicable laws and regulations.
